
|Articles|September 23, 2015
Shaji Kumar on Treatment-Related Adverse Events From Monoclonal Antibodies
Author(s)Shaji Kumar
Shaji Kumar, professor of medicine, Division of Hematology, Mayo Clinic, discusses common treatment-related adverse events from monoclonal antibodies in patients with multiple myeloma.
Advertisement
Shaji Kumar, professor of medicine, Division of Hematology, Mayo Clinic, discusses common treatment-related adverse events from monoclonal antibodies in patients with multiple myeloma.
The main adverse event that is seen is infusion reactions, Kumar says. These reactions are easily managed and, even so, usually go away on their own.
Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma
3
KTX-1001 Elicits Responses in Some With Multiple Myeloma
4
Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma
5




